PART II.
OTHER INFORMATION
ITEM 1.
LEGAL PROCEEDINGS
Information with respect to this item may be found in Note 12, Legal Proceedings and Contingencies, in our Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, of this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.
ITEM 1A.
RISK FACTORS
As of the date of this filing, the risk factors have not changed substantively from those disclosed in Part 1 Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2017, which risk factors are incorporated by reference in this report.
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In January 2018, our board of directors authorized the use of an additional $30.0 million for the repurchase of our common stock, which was announced on February 1, 2018.
In the three months ended March 31, 2018, we purchased approximately 0.5 million shares for approximately $33.3 million.
As of March 31, 2018, we had approximately $41.1 million remaining in our repurchase program, which has no expiration date.
Issuer Purchases of Equity Securities
All of the shares repurchased were pursuant to our publicly announced repurchase program.
ITEM 6.
EXHIBITS
All references in the table above to previously filed documents or descriptions are incorporating those documents and descriptions by reference thereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
